Skip to content
Back to search

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-19 - Tafamidis

Techniker KrankenkasseGermanyPublished on Oct 01, 2026
14 days left

Description

The TK aims to conclude discount contracts in accordance with § 130c para. 1 SGB V for the active substance Tafamidis (for lot allocation, see the respective lot designations) with all suitable pharmaceutical enterprises. The contract conclusion takes place within the framework of the TK's Open-House-Originale procedure: Individual negotiations on contract contents are not conducted, uniform conditions apply. The TK does not guarantee exclusivity to individual contracting partners. The contract duration is a maximum of 24 months, commencing 01.06.2025. The contract ends at the latest on 31.05.2027, regardless of the date of contract conclusion. In the event of patent expiry/expiry of market exclusivity before the aforementioned end date, the contract ends automatically at the end of the month of patent expiry/market exclusivity. Joining this Open-House-Originale procedure is possible at any time during the contract period. Due to the existence of industrial property rights with regard to the contract subject matter active substance or the procedure subject matter active substance combination, the participation and contract documents will only be made available to those pharmaceutical enterprises which offer/place on the market medicines with the procedure subject matter active substance or the procedure subject matter active substance combination or which credibly assure the TK that they wish to offer/place such medicines on the market during the contract period. The information provided on the binding period is not relevant in this case and is solely due to the mandatory requirements of the form. All further information can be found in the participation and contract documents.

CPV codes

Pharmaceutical products

Documents & submission

AI summary
Sign in for an AI summary

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Related tenders